insights_auto
Why is AGIO down 4.56%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$30.15
arrow_downward
-4.56%(-1.44) 1D
$29.55
arrow_downward
-1.99% (-0.60)bedtimeAfter hours
Closed: Nov 16, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$31.29
High
$31.70
Low
$30.10
Mkt. cap
1.80B
Avg. vol.
1.24M
Volume
540.85K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$31.29
High
$31.70
Low
$30.10
Mkt. cap
1.80B
Avg. vol.
1.24M
Volume
540.85K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
marketscreener.com
·
31 minutes ago
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
Yahoo Finance
·
34 minutes ago
What's dragging down the S&P 500? Apple in focus
Investing.com
·
46 minutes ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
ChartMill
·
2 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc